Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP461331.RA5L9xNGysyso3ZURbKZs9LmBpzDBVPsGL9WFNerbJpg4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP461331.RA5L9xNGysyso3ZURbKZs9LmBpzDBVPsGL9WFNerbJpg4130_assertion type Assertion NP461331.RA5L9xNGysyso3ZURbKZs9LmBpzDBVPsGL9WFNerbJpg4130_head.
- NP461331.RA5L9xNGysyso3ZURbKZs9LmBpzDBVPsGL9WFNerbJpg4130_assertion description "[K(ATP) channel mutations were most common (15%) followed by GLUD1 mutations causing hyperinsulinism with hyperammonemia (5.9%), and HNF4A mutations (5%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP461331.RA5L9xNGysyso3ZURbKZs9LmBpzDBVPsGL9WFNerbJpg4130_provenance.
- NP461331.RA5L9xNGysyso3ZURbKZs9LmBpzDBVPsGL9WFNerbJpg4130_assertion evidence source_evidence_literature NP461331.RA5L9xNGysyso3ZURbKZs9LmBpzDBVPsGL9WFNerbJpg4130_provenance.
- NP461331.RA5L9xNGysyso3ZURbKZs9LmBpzDBVPsGL9WFNerbJpg4130_assertion SIO_000772 20164212 NP461331.RA5L9xNGysyso3ZURbKZs9LmBpzDBVPsGL9WFNerbJpg4130_provenance.
- NP461331.RA5L9xNGysyso3ZURbKZs9LmBpzDBVPsGL9WFNerbJpg4130_assertion wasDerivedFrom befree-20150227 NP461331.RA5L9xNGysyso3ZURbKZs9LmBpzDBVPsGL9WFNerbJpg4130_provenance.
- NP461331.RA5L9xNGysyso3ZURbKZs9LmBpzDBVPsGL9WFNerbJpg4130_assertion wasGeneratedBy ECO_0000203 NP461331.RA5L9xNGysyso3ZURbKZs9LmBpzDBVPsGL9WFNerbJpg4130_provenance.